Infantile Hemangioma
17
1
1
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.8%
2 terminated out of 17 trials
81.8%
-4.7% vs benchmark
24%
4 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Timolol Maleate Gel for the Treatment of Infantile Hemangioma
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Nadolol for Proliferating Infantile Hemangiomas
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
Hemangiol, Post Marketing Surveillance Study
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
Optical Tomographic Imaging of Infantile Hemangiomas
A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo